Your browser doesn't support javascript.
loading
Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.
Bosma, Angela L; de Wijs, Linde E M; Hof, Michel H; van Nieuwenhuizen, Beau R; Gerbens, Louise A A; Middelkamp-Hup, Maritza A; Hijnen, DirkJan; Spuls, Phyllis I.
Afiliación
  • Bosma AL; Department of Dermatology, Amsterdam Public Health, Immunity and Infections, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: a.l.bosma@amsterdamumc.nl.
  • de Wijs LEM; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
  • Hof MH; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, the Netherlands.
  • van Nieuwenhuizen BR; Department of Dermatology, Amsterdam Public Health, Immunity and Infections, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Gerbens LAA; Department of Dermatology, Amsterdam Public Health, Immunity and Infections, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Middelkamp-Hup MA; Department of Dermatology, Amsterdam Public Health, Immunity and Infections, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Hijnen D; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
  • Spuls PI; Department of Dermatology, Amsterdam Public Health, Immunity and Infections, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, the Netherlands.
J Am Acad Dermatol ; 83(5): 1375-1384, 2020 Nov.
Article en En | MEDLINE | ID: mdl-32485210

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dermatitis Atópica / Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies Aspecto: Patient_preference Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: J Am Acad Dermatol Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dermatitis Atópica / Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies Aspecto: Patient_preference Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: J Am Acad Dermatol Año: 2020 Tipo del documento: Article